메뉴 건너뛰기




Volumn 2, Issue 3, 2009, Pages 39-43

Dissolution enhancement of carvedilol by using surfactant as a coating material

Author keywords

Antihypertensive; Surfactant; Tablet coating

Indexed keywords

CARVEDILOL; CITRIC ACID TRIETHYL ESTER; CROSPOVIDONE; LACTOSE; MAGNESIUM STEARATE; POLYSORBATE 80; POLYVINYL ALCOHOL; POVIDONE; SILICON DIOXIDE; ZOLPIDEM TARTRATE;

EID: 77953462016     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (8)
  • 1
    • 0023571649 scopus 로고    scopus 로고
    • Mollendorff EV, Reiff K, Neugebauer G: Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker. Eur J Clinical Pharm1987; 33:511-513.
    • Mollendorff EV, Reiff K, Neugebauer G: Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker. Eur J Clinical Pharm1987; 33:511-513.
  • 2
    • 85019039881 scopus 로고    scopus 로고
    • Development and Evaluation of Carvedilol Fast Dissolving Tablets Using Superdisintegrant and Solid Dispersion Technique
    • Sharma S, Gupta GD, Jain CP, Naruka PS: Development and Evaluation of Carvedilol Fast Dissolving Tablets Using Superdisintegrant and Solid Dispersion Technique. The Pharma review 2007.
    • (2007) The Pharma review
    • Sharma, S.1    Gupta, G.D.2    Jain, C.P.3    Naruka, P.S.4
  • 3
    • 84855509620 scopus 로고    scopus 로고
    • Ubaidulla U, Reddy MV, Ruckmani K, Ahmad F, Khar RK: Transdermal Therapeutic System of Carvedilol: Effect of Hydrophilic and Hydrophobic Matrix on In Vitro and In Vivo Characteristics. AAPS PharmSciTech2007; 8(1), article 2.
    • Ubaidulla U, Reddy MV, Ruckmani K, Ahmad F, Khar RK: Transdermal Therapeutic System of Carvedilol: Effect of Hydrophilic and Hydrophobic Matrix on In Vitro and In Vivo Characteristics. AAPS PharmSciTech2007; 8(1), article 2.
  • 4
    • 0032957957 scopus 로고    scopus 로고
    • Gehr TWB, Tenero DM, Boyle DA, QianY, Sica DA, Shusterman NH: The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency. Eur J Clin Pharmacoly1999; 55:269-277.
    • Gehr TWB, Tenero DM, Boyle DA, QianY, Sica DA, Shusterman NH: The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency. Eur J Clin Pharmacoly1999; 55:269-277.
  • 5
    • 0032212995 scopus 로고    scopus 로고
    • Bruce T, Vanderhoff MD, Heather M, Ruppel MD: Carvedilol: The New Role of Beta Blockers in Congestive Heart Failure. American Family Physician1988; 58 No. 7.
    • Bruce T, Vanderhoff MD, Heather M, Ruppel MD: Carvedilol: The New Role of Beta Blockers in Congestive Heart Failure. American Family Physician1988; 58 No. 7.
  • 6
    • 0028230799 scopus 로고    scopus 로고
    • Eichhorn EJ, Do beta-blockers have a role in patients with congestive heart failure? Cardiol Clin1994; 12: 133-42.
    • Eichhorn EJ, Do beta-blockers have a role in patients with congestive heart failure? Cardiol Clin1994; 12: 133-42.
  • 7
    • 77953398398 scopus 로고    scopus 로고
    • Beyer P, Reinholz E.EP 0 893 440 A1(1999).
    • Beyer P, Reinholz E.EP 0 893 440 A1(1999).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.